Workflow
Xin Lang Zheng Quan
icon
Search documents
恩捷股份12月31日获融资买入9763.98万元,融资余额16.01亿元
Xin Lang Zheng Quan· 2026-01-05 01:29
12月31日,恩捷股份跌0.86%,成交额12.75亿元。两融数据显示,当日恩捷股份获融资买入额9763.98 万元,融资偿还1.51亿元,融资净买入-5326.01万元。截至12月31日,恩捷股份融资融券余额合计16.03 亿元。 分红方面,恩捷股份A股上市后累计派现28.25亿元。近三年,累计派现18.74亿元。 机构持仓方面,截止2025年9月30日,恩捷股份十大流通股东中,泉果旭源三年持有期混合A (016709)位居第四大流通股东,持股3057.42万股,相比上期增加314.29万股。香港中央结算有限公司 位居第五大流通股东,持股2927.70万股,相比上期减少131.24万股。鹏华中证细分化工产业主题ETF联 接A(014942)位居第十大流通股东,持股875.70万股,为新进股东。 融资方面,恩捷股份当日融资买入9763.98万元。当前融资余额16.01亿元,占流通市值的2.88%,融资 余额超过近一年90%分位水平,处于高位。 责任编辑:小浪快报 融券方面,恩捷股份12月31日融券偿还1600.00股,融券卖出1900.00股,按当日收盘价计算,卖出金额 10.76万元;融券余量3.63万股, ...
步长制药12月31日获融资买入807.37万元,融资余额5.16亿元
Xin Lang Zheng Quan· 2026-01-05 01:29
Core Viewpoint - The financial performance and trading activity of Shandong Buchang Pharmaceutical Co., Ltd. indicate a mixed outlook, with a decline in revenue but a significant increase in net profit, alongside low financing and margin trading levels [1][2]. Group 1: Financial Performance - As of September 30, 2025, Buchang Pharmaceutical reported a revenue of 8.469 billion yuan, a year-on-year decrease of 0.54% [2]. - The net profit attributable to shareholders reached 868 million yuan, showing a substantial year-on-year increase of 177.54% [2]. - Cumulative cash dividends since the company's A-share listing amount to 7.948 billion yuan, with 1.609 billion yuan distributed over the past three years [2]. Group 2: Trading Activity - On December 31, 2025, Buchang Pharmaceutical's stock price fell by 0.38%, with a trading volume of 78.8184 million yuan [1]. - The financing buy amount for the day was 8.0737 million yuan, while the financing repayment was 12.3316 million yuan, resulting in a net financing outflow of 4.258 million yuan [1]. - The total margin trading balance stood at 518 million yuan, with the financing balance accounting for 3.13% of the circulating market value, indicating a low level compared to the past year [1]. Group 3: Shareholder Structure - As of September 30, 2025, the number of shareholders decreased to 51,100, a reduction of 7.36% [2]. - The average number of circulating shares per shareholder increased by 2.92% to 20,641 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited held 20.3871 million shares, an increase of 8.5127 million shares compared to the previous period [2].
来伊份12月31日获融资买入911.08万元,融资余额1.13亿元
Xin Lang Zheng Quan· 2026-01-05 01:29
Group 1 - The core viewpoint of the news is that Laiyifen's stock performance shows a mixed trend with significant financing activities and a notable decline in net profit [1][2] Group 2 - On December 31, Laiyifen's stock rose by 1.63% with a trading volume of 169 million yuan, while the financing buy-in amounted to 9.11 million yuan and the net financing buy-in was -8.74 million yuan [1] - As of December 31, the total balance of margin trading for Laiyifen was 113 million yuan, which represents 2.46% of its market capitalization, indicating a high level compared to the past year [1] - The company had no shares repaid in the securities lending market on December 31, with 5,600 shares sold, amounting to 76,900 yuan, and a remaining short position of 14,600 shares valued at 200,500 yuan, also indicating a high level compared to the past year [1] Group 3 - As of September 30, the number of Laiyifen shareholders decreased by 9.99% to 37,600, while the average circulating shares per person increased by 11.10% to 8,894 shares [2] - For the period from January to September 2025, Laiyifen reported a revenue of 2.854 billion yuan, a year-on-year increase of 13.12%, but the net profit attributable to the parent company was -125 million yuan, a decrease of 194.06% [2] - Since its A-share listing, Laiyifen has distributed a total of 314 million yuan in dividends, with 47.79 million yuan distributed over the past three years [2] - As of September 30, 2025, Tianhong Zhongzheng Food and Beverage ETF was the ninth largest circulating shareholder of Laiyifen, increasing its holdings by 6,530 shares to 527,900 shares [2]
通用股份12月31日获融资买入3245.37万元,融资余额4.04亿元
Xin Lang Zheng Quan· 2026-01-05 01:29
Group 1 - The core viewpoint of the news is that Jiangsu General Technology Co., Ltd. has experienced fluctuations in stock performance and financing activities, indicating a high level of trading activity and investor interest [1][2]. - On December 31, General shares fell by 3.41%, with a trading volume of 259 million yuan. The financing buy-in amount was 32.45 million yuan, while the financing repayment was 24.66 million yuan, resulting in a net financing buy of 7.79 million yuan [1]. - As of December 31, the total balance of margin trading for General shares was 405 million yuan, with a financing balance of 404 million yuan, accounting for 5.30% of the circulating market value, which is above the 90th percentile level over the past year [1]. Group 2 - As of September 30, the number of shareholders for General shares was 62,600, a decrease of 4.31% from the previous period, while the average circulating shares per person increased by 4.91% to 25,304 shares [2]. - For the period from January to September 2025, General shares achieved an operating income of 6.215 billion yuan, representing a year-on-year growth of 24.59%. However, the net profit attributable to shareholders decreased by 71.01% to 110 million yuan [2]. - Since its A-share listing, General has distributed a total of 589 million yuan in dividends, with 136 million yuan distributed over the past three years [3].
世纪华通拟3亿元至6亿元回购股份,公司股价年内涨0.00%
Xin Lang Zheng Quan· 2026-01-04 13:59
Group 1 - The company Century Huatong plans to repurchase shares through centralized bidding, with a repurchase amount between 300 million and 600 million yuan, and a maximum repurchase price of 25.97 yuan per share, which is 52.23% higher than the current price of 17.06 yuan [1] - The company has seen its stock price remain unchanged this year, with a cumulative increase of 0.00% [1] - The main business of Century Huatong includes network game development and operation, as well as the research, manufacturing, and sales of various automotive parts and related molds, with mobile games contributing 84.70% to revenue [1] Group 2 - As of September 30, the number of shareholders of Century Huatong reached 159,100, an increase of 48.40% compared to the previous period, while the average circulating shares per person decreased by 32.85% to 43,073 shares [2] - For the period from January to September 2025, Century Huatong achieved operating revenue of 27.223 billion yuan, a year-on-year increase of 75.31%, and a net profit attributable to shareholders of 4.357 billion yuan, up 141.65% year-on-year [2] - The company has distributed a total of 710 million yuan in dividends since its A-share listing, with no dividends distributed in the past three years [3]
东诚药业拟1亿元至2亿元回购股份,公司股价年内涨0.00%
Xin Lang Zheng Quan· 2026-01-04 13:33
Group 1 - The company plans to repurchase shares through centralized bidding, with a total amount between 100 million and 200 million yuan, and a maximum repurchase price of 18.00 yuan per share, which is 31.00% higher than the current price of 13.74 yuan [1] - The company reported a total revenue of 2.043 billion yuan for the period from January to September 2025, a year-on-year decrease of 5.52%, and a net profit attributable to shareholders of 149 million yuan, down 10.64% year-on-year [2] - The company has distributed a total of 1 billion yuan in dividends since its A-share listing, with 293 million yuan distributed over the past three years [3] Group 2 - As of September 30, 2025, the number of shareholders increased to 24,600, a rise of 4.51%, while the average circulating shares per person decreased by 4.32% to 30,191 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 20.0272 million shares, an increase of 7.607 million shares compared to the previous period [3]
歌尔股份回购进展:累计回购3449.70万股 占总股本0.97%
Xin Lang Zheng Quan· 2026-01-04 12:26
登录新浪财经APP 搜索【信披】查看更多考评等级 合规性说明 歌尔股份在公告中强调,本次回购严格遵循相关法律法规及监管要求。公司未在"可能对公司证券交易 价格产生重大影响的重大事项发生之日或决策过程中至依法披露之日内"等禁止期间实施回购,且集中 竞价交易委托符合深圳证券交易所规定,未以当日交易涨幅限制价格委托,亦未在开盘集合竞价、收盘 集合竞价及无涨跌幅限制交易日进行委托。 后续安排 公司表示,回购股份的实施符合既定方案及相关法律、法规要求。后续将根据市场情况在剩余回购期限 内继续推进回购计划,并按照规定及时履行信息披露义务。公告同时提醒广大投资者注意投资风险。 2026年1月5日,歌尔股份有限公司(以下简称"歌尔股份")发布回购股份进展公告,披露了截至2025年 12月31日的股份回购实施情况。公告显示,公司自2025年4月启动回购以来,已累计回购股份3449.70万 股,占公司总股本的0.97%。 回购方案回顾 据公告披露,歌尔股份于2025年4月10日召开第六届董事会第二十四次会议,审议通过了《关于回购公 司股份方案的议案》。根据该方案,公司拟使用自有资金和自筹资金,通过集中竞价交易方式回购部分 A股股 ...
晶澳科技股份回购进展:已耗资超2.17亿元,购得1540万股
Xin Lang Zheng Quan· 2026-01-04 11:54
根据公告,截至2025年12月31日,晶澳科技股份回购的具体实施情况如下: 15,404,377股 0.47% 14.236元/股 13.33元/股 217,199,530.71元 登录新浪财经APP 搜索【信披】查看更多考评等级 2026年1月5日,晶澳太阳能科技股份有限公司(以下简称"晶澳科技"或"公司")发布《关于回购公司股 份进展的公告》,披露截至2025年12月31日,公司股份回购计划已实施部分进展。公告显示,公司通过 深圳证券交易所交易系统以集中竞价交易方式累计回购股份1540.44万股,占当前总股本的0.47%,成交 总金额约2.17亿元,回购价格区间为13.33元/股至14.236元/股。 回购进展:累计购股1540万股,总金额超2.17亿元 上述数据显示,公司此次回购的股份数量为1540.44万股,占总股本比例0.47%;交易价格区间覆盖 13.33元/股至14.236元/股,整体交易均价约为14.09元/股(按总金额除以总股数计算);累计成交金额 为217,199,530.71元(不含印花税、交易佣金等费用),折合人民币约2.17亿元。 回购方案背景:拟斥资2-4亿元,用于员工激励 回溯公 ...
常青股份回购进展:已耗资2438万元回购197.25万股 完成下限81%
Xin Lang Zheng Quan· 2026-01-04 09:24
登录新浪财经APP 搜索【信披】查看更多考评等级 合肥常青机械股份有限公司(下称"常青股份")近日披露股份回购进展公告,截至2025年12月31日,公 司已通过集中竞价交易方式累计回购股份197.25万股,占总股本比例0.8289%,累计耗资2438.09万元 (不含交易费用),已完成预计回购金额下限的81.27%。 回购方案回顾 据公告,常青股份此次回购方案由公司控股股东及实际控制人之一、董事长兼总经理吴应宏先生于2025 年4月提议。2025年4月15日,公司第五届董事会第十二次会议审议通过回购预案,明确回购实施期限为 2025年4月15日至2026年4月14日,预计使用自有资金及商业银行回购专项贷款,以集中竞价交易方式回 购股份,金额区间为3000万元至5000万元,回购股份将全部用于员工持股计划或股权激励。 对于后续回购计划,常青股份称将在剩余实施期限(截至2026年4月14日)内,根据市场情况择机实施 回购,并按照监管要求及时履行信息披露义务。同时,公司提醒投资者注意回购实施过程中的市场风 险,理性决策。 作为一家专注于汽车冲压及焊接零部件的企业,常青股份此次回购用于员工持股计划或股权激励,被市 场 ...
华塑控股特定发行认购方湖北宏泰集团承诺:36个月内不减持本次认购股份
Xin Lang Zheng Quan· 2026-01-04 08:52
承诺背景与市场意义:为特定发行提供稳定性支撑 登录新浪财经APP 搜索【信披】查看更多考评等级 华塑控股股份有限公司(以下简称"华塑控股")于2025年12月31日发布公告称,公司十二届董事会第二 十七次临时会议已审议通过2025年度向特定对象发行股票相关议案。本次发行的认购对象湖北宏泰集团 有限公司(以下简称"湖北宏泰集团")已出具《关于特定期间不减持公司股票的承诺函》,明确在本次 发行完成后36个月内不减持所认购股份,以稳定市场预期。 承诺核心内容:36个月限售期覆盖直接及衍生股份 根据公告,湖北宏泰集团的承诺函包含三大核心条款。其一,明确限售期限与范围:自本次向特定对象 发行A股股票完成后36个月内,不减持本次认购的华塑控股股票;且在限售期内,因送股、资本公积金 转增股本等形式衍生取得的股票,同样需遵守上述限售安排。 其二,强调监管适应性:若前述限售期与证券监管机构最新监管意见或要求不符,将根据监管意见进行 调整;限售期届满后的减持行为,还需遵守《公司法》《证券法》《深圳证券交易所股票上市规则》等 法律法规及《公司章程》的规定。 其三,明确违约责任:若违反承诺减持股票,减持所得收益将全部归华塑控股所有, ...